RELATIONSHIP BETWEEN RECTAL MUCOSAL PROSTAGLANDIN PRODUCTION AND WATER AND ELECTROLYTE TRANSPORT IN ULCERATIVE-COLITIS

被引:34
|
作者
RAMPTON, DS [1 ]
SLADEN, GE [1 ]
机构
[1] GUYS HOSP, SCH MED, GASTROENTEROL UNIT, LONDON SE1 9RT, ENGLAND
关键词
D O I
10.1159/000199086
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In vivo rectal dialysis was used to test the hypothesis that the diarrhea of patients with active ulcerative colitis (UC) is due to inhibition of large intestinal salt and water absorption by enhanced local mucosal prostaglandin (PG) synthesis. In 28 patients with untreated UC, increased rectal mucosal PGE2 release varied inversely with Na transport and directly with K transport; higher PGE2 release was also associated with lower (i.e., less negative) potential difference (PD). Disease activity assessed sigmoidoscopically was positively related to PGE2 release, K transport and lower PD. Similar relationships were found in 33 patients treated with sulfasalazine and/or corticosteroids and in 9 patients studied serially when on unaltered conventional, or no treatment. When 10 patients with UC were given the PG synthesis inhibitor flurbiprofen, a significant fall in PGE2 release was associated with deteriorations in mucosal PD and transport of Na and K. Increased PG production is therefore unlikely to be a major determinant of the abnormalities of electrolyte transport found in UC. The correlations between mucosal PGE2 release and electrolyte transport were probably due to the relationship of these variables with some other consequence of tissue damage.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 50 条
  • [21] RECTAL MUCOSAL ADRENERGIC-INNERVATION AND ENTEROCHROMAFFIN CELLS IN ULCERATIVE-COLITIS AND IRRITABLE COLON
    KYOSOLA, K
    PENTTILA, O
    SALASPURO, M
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1977, 12 (03) : 363 - 367
  • [22] CURRENT SURGICAL THERAPY FOR MUCOSAL ULCERATIVE-COLITIS
    BINDEROW, SR
    WEXNER, SD
    DISEASES OF THE COLON & RECTUM, 1994, 37 (06) : 610 - 624
  • [23] MORPHOMETRY OF MALIGNANT MUCOSAL CHANGES IN ULCERATIVE-COLITIS
    ALLEN, DC
    HAMILTON, PW
    WATT, PCH
    PATTERSON, CC
    BIGGART, JD
    JOURNAL OF PATHOLOGY, 1987, 151 (01): : A66 - A67
  • [24] MUCOSAL DEHYDROGENASE-ACTIVITY IN ULCERATIVE-COLITIS
    VATN, MH
    ELGJO, K
    NORDHEIM, A
    BERGAN, A
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1983, 18 : 89 - 89
  • [25] MUCOSAL METABOLISM IN THE COLON AND ILEUM IN ULCERATIVE-COLITIS
    FINNIE, IA
    TAYLOR, BA
    RHODES, JM
    GASTROENTEROLOGY, 1993, 104 (04) : A700 - A700
  • [26] SURVIVAL WITH CARCINOMA ARISING IN MUCOSAL ULCERATIVE-COLITIS
    LAVERY, IC
    CHIULLI, RA
    JAGELMAN, DG
    FAZIO, VW
    WEAKLEY, FL
    ANNALS OF SURGERY, 1982, 195 (04) : 508 - 512
  • [27] DEFICIENCY OF COLONIC MUCOSAL CARBOXYPEPTIDASE IN ULCERATIVE-COLITIS
    CHADWICK, VS
    SCHLUPP, M
    COOPER, B
    BARBEZAT, G
    MORRIS, K
    FRIEND, G
    CHADWICK, D
    GASTROENTEROLOGY, 1987, 92 (05) : 1341 - 1341
  • [28] ULTRASONIC MUCOSAL PROCTECTOMY IN PATIENTS WITH ULCERATIVE-COLITIS
    HEIMANN, TM
    SLATER, G
    KURTZ, RJ
    SZPORN, A
    GREENSTEIN, AJ
    ANNALS OF SURGERY, 1989, 210 (06) : 787 - 791
  • [29] RECTAL MUCOSA PROSTACYCLIN FORMATION IN ULCERATIVE-COLITIS
    SINZINGER, H
    SILBERBAVER, K
    SEYFRIED, H
    LANCET, 1979, 1 (8113): : 444 - 444
  • [30] RECTAL BISMUTH SUBSALICYLATE AS THERAPY FOR ULCERATIVE-COLITIS
    RYDER, SD
    WALKER, RJ
    JONES, H
    RHODES, JM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1990, 4 (04) : 333 - 338